Company Information
USD
36.4
- (0.9%)
NASDAQ:SWTX, SPRINGWORKS THERAPEUTICS, INC.
Industry: Biotechnology
End of Day: 25 June 2024 GMT-4
SpringWorks Therapeutics Inc is a clinical stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers.
Address
100 Washington Boulevard
Classification
Sector
Healthcare
Industry Group
Biotechnology
Industry
Biotechnology
Key Executives
Dr. Freda C. Lewis-Hall,M.D.
Director
Mr. Alan Fuhrman
Director
Mr. Francis I. Perier, Jr
CFO
Mr. Carlos Alban
Director
Mr. Saqib Islam, J.D.
CEO/Director
Mr. Daniel S. Lynch, M.B.A.
Chairman of the Board/Director
Dr. Julie Hambleton, M.D.
Director
Mr. Michael Nofi
Chief Accounting Officer
Mr. Tai-An Lin
Chief Scientific Officer
Dr. Kristin Patterson, PhD
Chief Technology Officer
Mr. Herschel S. Weinstein, J.D.
General Counsel/Secretary
Dr. Badreddin Edris, PhD
COO
Mr. Daniel Pichl
Other Executive Officer
Mr. Bhavesh Ashar, M.B.A.
Other Executive Officer
Dr. James Cassidy, M.D.,PhD
Chief Medical Officer
Ownership
Institution Holdings
FMR Inc
10,809,235 (14.649%)
FMR LLC
9,360,090 (12.989%)
Vanguard Group Inc
6,036,542 (8.181%)
Fidelity Management & Research Company LLC
5,679,538 (7.697%)
BlackRock Inc
5,382,184 (7.294%)
Fidelity Management Trust Company
4,407,629 (5.973%)
Deep Track Capital, LP
4,063,676 (5.507%)
Boxer Capital LLC
3,421,541 (4.637%)
Orbimed Advisors, LLC
3,219,359 (4.363%)
BC SW, LP
3,081,307 (4.276%)
Individual Holdings
Mr. Daniel S. Lynch, M.B.A.
301,849 (0.483%)
Dr. Badreddin Edris, PhD
269,600 (0.374%)
Mr. Saqib Islam, J.D.
256,264 (0.356%)
Dr. James Cassidy, M.D.,PhD
76,416 (0.106%)
Mr. Francis I. Perier, Jr,M.B.A.
59,253 (0.082%)
Mr. Bhavesh Ashar, M.B.A.
58,154 (0.081%)
Mr. Herschel S. Weinstein, J.D.
52,239 (0.073%)
Mr. Daniel Pichl
45,212 (0.063%)
Mr. Tai-An Lin
29,289 (0.041%)
Mr. Michael Nofi
28,727 (0.040%)
Funds Holdings
Fidelity Growth Company Commingled Pool
4,407,629 (5.973%)
Fidelity Growth Company Fund
3,410,145 (4.622%)
Vanguard Total Stock Market Index Fund
1,926,016 (2.610%)
Vanguard US Total Market Shares ETF
1,926,016 (2.610%)
iShares Russell 2000 ETF
1,648,530 (2.234%)
Vanguard Small Cap Index
1,564,164 (2.120%)
SPDR® S&P Biotech ETF
1,355,364 (1.837%)
Fidelity Growth Company K6 Fund
1,210,887 (1.641%)
T. Rowe Price Health Sciences Fund
1,050,125 (1.423%)
Fidelity Series Growth Company Fund
954,749 (1.294%)
Make Smart Investment Choices
GoodWhale Pte. Ltd.
1557 Keppel Road, #01-01
Singapore 089066
Singapore 089066
